Skip to content
  • Facebook
  • Twitter
  • Instagram
  • Email

ORCHESTRA Cohort

A Horizon 2020 cohort

  • Project
  • Community
  • Contact

ORCHESTRA goes ECCMID 2024

ORCHESTRA goes ECCMID 2024

27.03.2024

 

ORCHESTRA proudly presents a vast variety of research results at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), held from April 27-30 2024 in Barcelona, Spain.

 

ECCMID is one of the largest conferences in the field of clinical microbiology and infectious diseases in Europe and brings together leading experts and professionals in its field. ECCMID 2024 again promises exciting presentations and discussions, and ORCHESTRA contributes to it with 13 accepted submissions.

 

Download the overview of all ORCHESTRA ECCMID presentations here.

 

The ORCHESTRA project will be presented to the congress audience on 29 April 10.00-10.30 with a dedicated session at the ECCMID Fireplace.

 

ECCMID Scientific Programme | Venue Plan | ORCHESTRA Website

 

The oral and poster sessions presented by ORCHESTRA researchers include comprehensive analysis of COVID-19 research and response strategies, investigating the long-COVID syndrome, neurosensorial assessments, immunological responses to vaccines, gut microbiota dynamics, DNA methylation changes, viral evolution, and therapeutic interventions.

 

The oral presentations of this year aim to optimize evidence generation in the field of infectious diseases, especially during pandemics. WP2 looked at Post-COVID-Condition dynamics with a Latent Transition Analysis. WP1 introduces the Cohort Coordination Board (CCB), which offers a trusted environment for exchange and discussion.

 

The posters target a wide range of COVID-19 research, reflecting the wide scope of research that ORCHESTRA undertakes. Among others, researchers in ORCHESTRA assessed the mRNA vaccine effectiveness in people living with HIV (PLWH), developed a multi-scale model integrating viral kinetics, disease severity, and transmission risk to anticipate the impact of antiviral strategies, and monitored Italian healthcare workers to determine the incidence, characteristics, and clinical course of SARS-CoV-2 breakthrough infections.

###

ORCHESTRA has received funding from the European Union’s Horizon 2020
research and innovation programme under grant agreement No 101016167.

Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic
EU Call: H2020-SC1-PHE-CORONAVIRUS-2020-2-RTD
Start date: 1 December 2020   End date: 30 November 2024
Coordinated by: UNIVERSITA DEGLI STUDI DI VERONA

© 2024 Orchestra. All right reserved.   Privacy Policy   Imprint